Akebia Therapeutics | AKBA - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Acadia Pharmaceuticals USD 148.57M 12.22M 2026-06
Agios Pharmaceuticals USD 38.46M 4.51M 2026-03
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
Amgen USD 1.72B 134M 2026-06
Ardelyx USD 101.44M 827K 2026-06
Astellas Pharma JPY 215.07B 19.63B 2026-06
AstraZeneca USD 4.07B 1.73B 2026-09
Bayer EUR 3.96B 267M 2026-06
BioMarin Pharmaceutical USD 333.64M 61.91M 2026-09
Celltrion KRW 12.72B 3.4B 2026-06
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 13.56M 1.09M 2026-06
Exelixis USD 154.56M 6.93M 2026-09
Fresenius Medical Care EUR 736.01M 12.99M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
J&J USD 6.25B 168M 2026-09
Kangmei Pharma CNY 253.72M 16.66M 2026-06
Karyopharm Therapeutics USD 10.42M 861K 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Moderna USD 216M 43M 2026-06
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 26.51M 4.5M 2026-06
Ovoca Bio EUR 617K 15K 2025-12
Pharma Mar EUR 15.53M 1.59M 2026-09
Prothena USD 10.9M 1.77M 2026-06
PTC Therapeutics USD 80.63M 6.74M 2026-06
Qiagen NV USD 142.33M 60K 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.31B 325M 2026-09
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Sartorius EUR 216.6M 4.7M 2026-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tectonic Therapeutic USD 6.17M 260K 2026-06
Tilray USD 24.85M 1.7M 2025-09
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 267.85M 44.71M 2026-09